Neoadjuvant high-dose intraarterial infusion chemotherapy under percutaneous pelvic perfusion with extracorporeal chemofiltration in patients with stages IIIa-IVa cervical cancer

Gynecologic Oncology

Volumn 95, Issue 3, 2004, Pages 576-582

  Motoyama, Satoru ^a   Hamana, Shinya ^a   Ku, Yonson ^a   Laoag Fernandez, Jovelle B ^a   Deguchi, Masashi ^a   Yoshida, Shigeki ^a   Tominaga, Masahiro ^a   Iwasaki, Takeshi ^a   Ohara, Noriyuki ^a   Maruo, Takeshi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemofiltration; High dose chemotherapy; Intraarterial infusion; Pelvic perfusion; Uterine cervical cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DRUG MEGADOSE; EXTRACORPOREAL CIRCULATION; FEMALE; HISTOLOGY; HUMAN; INFUSION; PATIENT SELECTION; PELVIS; PRIORITY JOURNAL; SKIN ABSORPTION; SURVIVAL RATE; TECHNIQUE; TREATMENT OUTCOME; TUMOR VOLUME; ULTRAFILTRATION; UTERINE CERVIX CANCER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; MIDDLE AGED; MITOMYCIN; NEOADJUVANT THERAPY; NEOPLASM STAGING; PEPLOMYCIN; UTERINE CERVICAL NEOPLASMS;

EID: 9944261500     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.08.027     Document Type: Article

References (51)

1. P.B. Panici, G. Scambia, G. Baiocchi, S. Greggi, G. Ragusa, and A. Gallo Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival Cancer 67 1991 372 379
2. C. Sananes, A. Giaroli, A. Soderini, N. Guardado, L. Snaidas, and A. Bermudez Neoadjuvant chemotherapy followed by radical hysterectomy and postoperative adjuvant chemotherapy in the treatment of carcinoma of the cervix uteri: long-term follow-up of a pilot study Eur. J. Gynaecol. Oncol. 19 1998 368 373
3. C.W. Whitney, W. Sause, B.N. Bundy, J.H. Malfetano, E.V. Hannigan, and W.C. Fowler Jr. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J. Clin. Oncol. 17 1999 1339 1348
4. M.S. Piver, and W.S. Chung Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma Obstet. Gynecol. 46 1975 507 510
5. S.A. Cannistra, and J.M. Niloff Cancer of the uterine cervix N. Engl. J. Med. 334 1996 1030 1038
6. M. Morris, P.J. Eifel, J. Lu, P.W. Grigsby, C. Levenback, and R.E. Stevens Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N. Engl. J. Med. 340 1999 1137 1143
7. R. Pearcey, M. Brundage, P. Drouin, J. Jeffrey, D. Johnston, and H. Lukka Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix J. Clin. Oncol. 20 2002 966 972
8. W.J. Koh Controversies in the radiotherapeutic management of cervical cancer J. Clin. Oncol. 21 Suppl. 10 2003 218 223
9. P.G. Rose Combined-modality therapy of locally advanced cervical cancer J. Clin. Oncol. 21 Suppl. 10 2003 211 217
10. P.G. Rose, and B.N. Bundy Chemoradiation for locally advanced cervical cancer: does it help? J. Clin. Oncol. 20 2002 891 893
11. M. Morris, P.J. Eifel, T.W. Burke, M.M. McNamara, C. Levenback, and J.J. Kavanagh Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy Gynecol. Oncol. 57 1995 72 78
12. H. Sueyama, M. Nakano, K. Sakumoto, T. Toita, Y. Takizawa, and H. Moromizato Intra-arterial chemotherapy with cisplatin followed by radical radiotherapy for locally advanced cervical cancer Gynecol. Oncol. 59 1995 327 332
13. T. Sugiyama, T. Nishida, Y. Hasuo, K. Fujiyoshi, and M. Yakushiji Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer Gynecol. Oncol. 69 1998 130 136
14. T. Sugiyama, Y. Hasuo, T. Nishida, and T. Kamura Impact on survival following successful neoadjuvant chemotherapy and radical surgery for Stage IIb bulky and Stage IIIb cervical cancer Gynecol. Oncol. 81 2001 330 331
15. Y. Aoki, T. Sato, M. Watanabe, M. Sasaki, I. Tsuneki, and K. Tanaka Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma Gynecol. Oncol. 81 2001 496 499
16. Y. Yamakawa, M. Fujimura, T. Hidaka, S. Hori, and S. Saito Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer Gynecol. Oncol. 77 2000 264 270
17. S. Hamana, S. Motoyama, S. Takeuchi, Y. Ku, S. Yoshida, and Y. Miyahara Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum Am. J. Clin. Oncol. 24 2001 241 246
18. S. Motoyama, S. Takeuchi, S. Hamana, Y. Ku, Y. Miyahara, and Y. Tateiwa Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: II. Its impact on clinical response and subsequent surgery Am. J. Clin. Oncol. 24 2001 247 250
19. Japan Society for Cancer Therapy Criteria for the evaluation of the clinical effects of solid cancer chemotherapy J. Jpn. Soc. Cancer Ther. 28 1998 101 130
20. W.A. Peters III, P.Y. Liu, R.J. Barrett II, R.J. Stock, B.J. Monk, and J.S. Berek Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J. Clin. Oncol. 18 2000 1606 1613
21. H.M. Keys, B.N. Bundy, F.B. Stehman, L.I. Muderspach, W.E. Chafe, and CL Suggs III Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N. Engl. J. Med. 340 1999 1154 1161
22. P.G. Rose, B.N. Bundy, E.B. Watkins, J.T. Thigpen, G. Deppe, and M.A. Maiman Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N. Engl. J. Med. 340 1999 1144 1153
23. C.W. Whitney Multimodality therapy in advanced cervical carcinoma Curr. Opin. Obstet. Gynecol. 2 1990 85 91
24. B.M. Sood, G.R. Gorla, M. Garg, P.S. Anderson, A.L. Fields, and C.D. Runowicz Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy Cancer 97 2003 1781 1788
25. J.A. Green, J.M. Kirwan, J.F. Tierney, P. Symonds, L. Fresco, and M. Collingwood Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis Lancet 358 2001 781 786
26. F. Kirsten, K.H. Atkinson, J.V. Coppleson, P.M. Elliott, D. Green, and R. Houghton Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer Br. J. Obstet. Gynaecol. 94 1987 583 588
27. S. Adachi, T. Ogasawara, H. Tsubamoto, H. Oku, Y. Hori, and Y. Tsuji Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer Int. J. Clin. Pharmacol. Res. 21 2001 105 110
28. H. Tsuda, M. Tanaka, T. Manabe, S. Nakata, O. Ishiko, and K. Yamamoto Phase I-II study of neoadjuvant chemoradiotherapy followed by radical surgery in locally advanced cervical cancer Anticancer Drugs 12 2001 853 858
29. Y. Aoki, T. Sato, M. Watanabe, M. Sasaki, I. Tsuneki, and K. Tanaka Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma Gynecol. Oncol. 81 2001 496 499
30. N. Nagai, T. Oshita, J. Murakami, K. Shigemasa, Y. Hirokawa, and K. Ohama Radiotherapy combined with transcatheter arterial infusion of cisplatin versus oral fluoropyrimidine anticancer agent for locally advanced carcinoma of the uterine cervix: a prospective follow-up study Oncol. Rep. 8 2001 119 125
31. H. Saitoh, Y. Nagata, M. Mitsumori, M. Kokubo, and M. Hiraoka Angiographic changes in uterine cervical cancer during the course of transarterial infusion chemotherapy Radiat. Med. 17 1999 305 309
32. O. Ishiko, T. Sumi, T. Yasui, Y. Matsumoto, N. Kawamura, and S. Ogita Balloon-occluded arterial infusion chemotherapy, simple total hysterectomy, and radiotherapy as a useful combination-Therapy for advanced cancer of the uterine cervix Oncol. Rep. 7 2000 141 144
33. P. Falappa, L. Trodella, A.R. Cotroneo, and A. Turriziani Advanced carcinoma of the cervix treated by continuous pelvic arterial infusion with cytostatics and radiation therapy Eur. J. Radiol. 2 1982 307 309
34. A.W. Chaney, P.J. Eifel, M.D. Logsdon, M. Morris, and J.T. Wharton Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix Int. J. Radiat. Oncol. Biol. Phys. 45 1999 113 118
35. R. Fujiwaki, Y. Maede, Y. Ohnishi, Y. Watanabe, K. Hata, and K. Miyazaki Prognosis of patients with stage IIIb-IVa squamous cell carcinoma of the cervix following intra-arterial neoadjuvant chemotherapy J. Exp. Clin. Cancer Res. 18 1999 143 146
36. Y. Minagawa, J. Kigawa, T. Irie, M. Okada, Y. Kanamori, and N. Terakawa Radical surgery following neoadjuvant chemotherapy for patients with stage IIIB cervical cancer Ann. Surg. Oncol. 5 1998 539 543
37. T. Sugiyama, T. Nishida, Y. Hasuo, K. Fujiyoshi, and M. Yakushiji Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer Gynecol. Oncol. 69 1998 130 136
38. Y. Nagata, N. Araki, H. Kimura, K. Fujiwara, K. Okajima, and T. Aoki Neoadjuvant chemotherapy by transcatheter arterial infusion method for uterine cervical cancer J. Vasc. Interv. Radiol. 11 2000 313 319
39. N. Itoh, M. Sawairi, T. Hanabayashi, H. Mori, Y. Yamawaki, and T. Tamaya Neoadjuvant intraarterial infusion chemotherapy with a combination of mitomycin-C, vincristine, and cisplatin for locally advanced cervical cancer: a preliminary report Gynecol. Oncol. 47 1992 391 394
40. H. Onishi, M. Yamaguchi, K. Kuriyama, T. Tsukamoto, K. Ishigame, and T. Ichikawa Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy Cancer J. Sci. Am. 6 2000 40 45
41. G.L. Eddy, A. Manetta, R.D. Alvarez, L. Williams, and W.T. Creasman Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study Gynecol. Oncol. 57 1995 412 416
42. M.H. Tattersall, V. Lorvidhaya, V. Vootiprux, A. Cheirsilpa, F. Wong, and T. Azhar Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association J. Clin. Oncol. 13 1995 444 451
43. D.J. Tinga, J. Bouma, and J.G. Aalders Patients with squamous cell versus adeno(squamous) cancer of the cervix, what factor determine the prognosis? Int. Gynecol. Cancer 2 1992 83 91
44. K.Y. Terada, G.W. Morley, and J.A. Roberts Stage Ib cancer of the cervix with lymph node metastases Gynecol. Oncol. 31 1988 389 395
45. T.W. Burke, W.J. Hoskins, P.B. Heller, M.C. Bibro, E.B. Weister, and R.C. Park Prognostic factors associated with radical hysterectomy failure Gynecol. Oncol. 26 1987 153 159
46. S. Park, B. Kim, J. Kim, J. Lee, E. Lee, and K. Lee Phase I/II study of neoadjuvant intraarterial chemotherapy with mitomycin-C, vincristine, and cisplatin in patients with stage IIb bulky cervical cancer Cancer 76 1995 814 823
47. B. Leone, C. Vallejo, J. Perez, M.A. Cuevas, M. Machiavelli, and J. Lacava Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical cancer Am. J. Clin. Oncol. 19 1996 132 135
48. J. Kigawa, Y. Minagawa, H. Ishihara, H. Itamochi, Y. Kanamori, and N. Terakawa The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer Am. J. Clin. Oncol. 19 1996 255 259
49. P.W. Grigsby, K. Heydon, D.G. Mutch, R.Y. Kim, and P. Eifel Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes Int. J. Radiat. Oncol. Biol. Phys. 15 2001 982 987
50. P.W. Grigsby, A.K. Singh, B.A. Siegel, F. Dehdashti, J. Rader, and I. Zoberi Lymph node control in cervical cancer Int. J. Radiat. Oncol. Biol. Phys. 59 2004 706 712
51. H.M. Keys, B.N. Bundy, F.B. Stehman, T. Okagaki, D.G. Gallup, and A.F. Burnett Radiation therapy with and without extrafascial hysterectomy for bulky stage Ib cervical carcinoma: a randomized trial of the Gynecologic Oncology Group Gynecol. Oncol. 89 2003 343 353